Karen Akinsanya

Insider Reports History

Location
Schrodinger, Inc., 120 West 45 Th Street, 17 Th Floor, New York, NY
Signature
/s/ Mathew B. Murphy, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Karen Akinsanya:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Schrodinger, Inc. President of R&D, Therapeutics Common Stock 15.6K $391K $25.00 Apr 14, 2025 Direct
Nautilus Biotechnology, Inc. Director Stock Option (Right to Buy) 45K Jun 23, 2025 Direct
Schrodinger, Inc. President of R&D, Therapeutics Stock Option (right to buy) 0 Apr 14, 2025 Direct

Insider Reports Filed by Karen Akinsanya

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NAUT Nautilus Biotechnology, Inc. Jun 23, 2025 1 $0 4 Jun 25, 2025 Director
SDGR Schrodinger, Inc. Apr 14, 2025 7 -$367K 4 Apr 15, 2025 President of R&D, Therapeutics
SDGR Schrodinger, Inc. Mar 3, 2025 2 $0 4 Mar 4, 2025 President of R&D, Therapeutics
NAUT Nautilus Biotechnology, Inc. Jun 14, 2024 1 $0 4 Jun 17, 2024 Director
SDGR Schrodinger, Inc. Mar 4, 2024 1 $0 4 Mar 5, 2024 President of R&D, Therapeutics
NAUT Nautilus Biotechnology, Inc. Jun 15, 2023 1 $0 4 Jun 16, 2023 Director
SDGR Schrodinger, Inc. Feb 9, 2023 1 $0 4 Feb 10, 2023 President of R&D, Therapeutics
NAUT Nautilus Biotechnology, Inc. Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
NAUT Nautilus Biotechnology, Inc. Mar 30, 2022 1 $0 4 Mar 31, 2022 Director
NAUT Nautilus Biotechnology, Inc. Mar 30, 2022 0 $0 3 Mar 31, 2022 Director
SDGR Schrodinger, Inc. Feb 9, 2022 1 $0 4 Feb 9, 2022 EVP, Chief Biomedical Scientist, Head of Discovery R&D
SDGR Schrodinger, Inc. Oct 15, 2021 3 -$71.6K 4 Oct 19, 2021 EVP, Chief Biomedical Scientist, Head of Discovery R&D
SDGR Schrodinger, Inc. Sep 15, 2021 3 -$79.2K 4 Sep 16, 2021 EVP, Chief Biomedical Scientist, Head of Discovery R&D
SDGR Schrodinger, Inc. Aug 16, 2021 8 -$1.78M 4 Aug 17, 2021 EVP, Chief Biomedical Scientist, Head of Discovery R&D
SDGR Schrodinger, Inc. Jun 7, 2021 7 -$1.19M 4 Jun 9, 2021 EVP, Chief Biomedical Scientist, Head of Discovery R&D